| Identification | Back Directory | [Name]
PITAVASTATIN LACTONE | [CAS]
141750-63-2 | [Synonyms]
PITAVASTATIN LACTONE
Pitavastatin calcium impurity D
Pitavastatin Lactone DISCONTINUED
(4R,6S,E)-6-[2-[2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]vinyl]tetrahydro-4-hydroxypyran-2-one
Pitavastatin calciuM interMediates to 5, (4R, 6S, E) -6 - [2 - cyclopropyl-4 - (4 - fluorophenyl) -3 - quinoline - yl - vinyl] -4 - hydroxy -3,4,5,6 - tetrahydro-2H-pyran-2 - one | [EINECS(EC#)]
1592732-453-0 | [Molecular Formula]
C25H22FNO3 | [MOL File]
141750-63-2.mol | [Molecular Weight]
403.45 |
| Chemical Properties | Back Directory | [Appearance]
White to Off-White Powder | [Melting point ]
92-95°C | [alpha ]
D32 +8.84° (c = 0.92 in chloroform) | [Boiling point ]
616.9±55.0 °C(Predicted) | [density ]
1.372±0.06 g/cm3(Predicted) | [pka]
13.25±0.40(Predicted) |
| Hazard Information | Back Directory | [Chemical Properties]
White to Off-White Powder | [Uses]
Lactone form of Pitavastatin; a HMG-CoA reductase inhibitor. Recent studies have shown that conversion between acid and lactone forms occurs in the body, drug-drug interaction should be considered on both acid and lactone forms. |
|
|